Myomo (MYO) Projected to Post Quarterly Earnings on Monday

Myomo (NYSEAMERICAN:MYOGet Free Report) is projected to announce its earnings results before the market opens on Monday, March 10th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $9.90 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Myomo Price Performance

Shares of NYSEAMERICAN:MYO opened at $4.60 on Friday. Myomo has a 52-week low of $2.51 and a 52-week high of $7.17. The stock has a market capitalization of $139.15 million, a PE ratio of -20.00 and a beta of 1.68.

Analysts Set New Price Targets

Several research firms have recently issued reports on MYO. HC Wainwright reaffirmed a “buy” rating and set a $7.50 price objective on shares of Myomo in a research report on Wednesday, November 13th. Craig Hallum upped their target price on Myomo from $7.00 to $9.00 and gave the company a “buy” rating in a research report on Friday, December 13th. Finally, Ascendiant Capital Markets upped their target price on Myomo from $8.50 to $9.00 and gave the company a “buy” rating in a research report on Tuesday, November 12th.

Read Our Latest Report on Myomo

Myomo Company Profile

(Get Free Report)

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.

Featured Stories

Earnings History for Myomo (NYSEAMERICAN:MYO)

Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.